Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
680.65
Change Change %
8.50 1.26%

Updated:24 May, 2019, 15:59 PM IST

BSE
680.90
Change Change %
9.95 1.48%

Updated:24 May, 2019, 16:01 PM IST

Aurobindo Pharma's Financial Summary

View last 5 years Financial Summary

Parameter MAR'18
(₹ Cr.)
MAR'17
(₹ Cr.)
Change %
Net Profit Before Taxes 2,342.94 2,178.57 7.54%
Adjustments for Expenses & Provisions 325.17 303.90 7.00%
Adjustments for Liabilities & Assets -1,224.59 457.02 -367.95%
Cash Flow from operating activities 913.55 2,457.20 -62.82%
Cash Flow from investing activities -981.45 -1,542.05 36.35%
Cash Flow from financing activities 439.69 -1,328.99 133.08%
Effect of exchange fluctuation on translation reserve 0.00 0.00 0.00%
Net increase/(decrease) in cash and cash equivalents 371.79 -413.84 189.84%
Opening Cash & Cash Equivalents -129.94 283.90 -145.77%
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0.00 0.00 0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations 0.00 0.00 0.00%
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0.00 0.00 0.00%
Effect of Foreign Exchange Fluctuations 0.00 0.00 0.00%
Closing Cash & Cash Equivalent 241.85 -129.94 286.12%
Top